Colon Polyps and Cancer
Colon
cancer is very common and is a leading cause of cancer deaths. In
almost every case, colon cancer starts out as a colon polyp. Therefore,
removing polyps prevents colon cancer. If someone in your immediate
family,parents, brother, sister, children – has had colon polyps, and,
especially colon cancer, then you are at increased risk. African
Americans have an increased death rate from the disease. The bottom line
is that almost anyone can develop colon cancer and that it is
preventable by removing polyps.
The
science on this question is slowly becoming clear. In some people it is
determined by genes. Some genes cause a huge number of colon polyps at a
very early age. Colon cancer develops in all these individuals and the
only cure is to remove the colon. Other cancer causing genes are not so
devastating but they are still important. However, there are many
people with colon cancer with no family history of polyps or cancer at
all.
The
first thing that is done by the physician is to take a careful medical
history and do a digital rectal exam. Colonoscopy is almost always
recommended as this is the only way to see the entire colon, remove
polyps and do biopsies. Colonoscopy uses a lighted, flexible tube and is
done under light sedation. Virtual colonoscopy uses an advanced form of
x-ray. It is fairly good at detecting polyps and tumors, but of course,
these can not be removed or biopsied. An older exam called a barium
enema is helpful at times, but not often done anymore.
Rural
Africans eat over 50 grams of fiber a day and have little colon cancer.
Indeed, they have few, if any, ills that affect the colon in the
Western World such as chronic colitis and diverticulosis. Yet, when this
ethnic group comes to North America, they have a high incidence of all
these diseases. This may be a coincidence, but I doubt it. Fiber in
plant food is now known to have many health benefits. A more recently
uncovered form of soluble plant fiber is Prebiotics.
These fibers fuel the good bacteria in the colon producing substances
which have been clearly shown to be healthy. In some animal studies,
they reduce the occurrence of experimental colon cancer. We still don’t
know the full cancer prevention benefits in humans but they are likely
to be found to be important.
Geier MS et al; Cancer Biol Ther. 2006; 5(10): P-1265-9
Colorectal cancer (CRC) is the third most common form of cancer. Current treatments including chemotherapy, radiotherapy and surgery are all associated with a high risk of complications and are not always successful, highlighting the need to develop new treatment strategies. The ingestion of probiotics, prebiotics or combinations of both (synbiotics) represents a novel new therapeutic option. Probiotics and prebiotics act to alter the intestinal microflora by increasing concentrations of beneficial bacteria such as lactobacillus and bifidobacteria, and reducing the levels of pathogenic micro-organisms. This strategy has the potential to inhibit the development and progression of neoplasia via mechanisms including; decreased intestinal inflammation, enhanced immune function and anti-tumorigenic activity, binding to potential food carcinogens including toxins found in meat products, and a reduction in bacterial enzymes which hydrolyse precarcinogenic compounds, such as beta-glucuronidase. There is substantial experimental evidence to suggest that probiotics and prebiotics may be beneficial in the prevention and treatment of colon cancer, however to date there have been few conclusive human trials. Probiotics and prebiotics have the potential to impact significantly on the development, progression and treatment of colorectal cancer and may have a valuable role in cancer prevention.
Kim YS, Milner JA; J Nutr. 2007; 137(11 Suppl): P-2576S
Colon cancer remains a significant global health concern. The impact of specific dietary components on colon tissue likely depends on a host of genomic processes that influence the growth, development, and differentiation of the epithelial cells at the colon crypt surface, where the balance between proliferation and differentiation is maintained possibly through the Wnt (beta-catenin/T-cell factor) signaling pathway. A loss of balance caused by either genetic mutations or environmental factors such as dietary habits can modulate the risk for the formation of aberrant crypt foci and ultimately the development of colon cancer. Evidence exists that butyrate reduces the number and the size of aberrant crypt foci in the colon. Butyrate is a natural histone deacetylase inhibitor as well as a molecule involved with enhanced TGF-beta-induced SMAD3 phosphorylation, increased IFN-gamma-mediated apoptosis, and altered expression of the intestinal muc2 gene that is responsibl e for mucin synthesis. Other dietary components, such as vitamin D and (n-3) fatty acids, may regulate proliferative properties of colon progenitor cells as well as the differentiation of subcellular lineages. Although these findings are intriguing, there are uncertainties that remain to be resolved including the optimal exposure needed to bring about an effect, the appropriate timing of administration, and if nutrient-nutrient and nutrient-gene interactions determine the overall response. The expanded use of high-throughput technologies, knowledge about the expression of genes and protein fingerprints, and metabolomic profiling will assist in addressing these issues and ultimately in determining the physiological significance of bioactive food components as cancer protectants.
Article printed from Jackson GI: http://www.jacksongi.com
URL to article: http://www.jacksongi.com/disease/colon-polyps-and-cancer/
Click here to print.